Research Reports | Market Assessment
$24,750.00
December 2021

Angelman Syndrome – Executive Insights – Angelman Syndrome

Table of contents

  • Angelman Syndrome - Executive Insights - Angelman Syndrome
    • Angelman Syndrome
Andrea Witt, Ph.D.
Andrea Witt, Ph.D.

Andrea S. Witt, Ph.D., is Therapy Leader of the Central Nervous System and Ophthalmology Disorders Portfolio at Clarivate, where she oversees a team of Business Insights Analysts and Senior Directors responsible for market research encompassing Neurology, Psychiatry, Pain, and Ophthalmology.

Her interests beyond specific CNS indications included the market potential for neuroprotectants and the impact of biomarkers on CNS markets. Dr. Witt’s research, analysis, and commentaries have appeared in Barron’s, Pharmaceutical Executive, PharmaVoice, Nature Medicine, and CNBC. Dr. Witt’s previous experience includes 10 years of scientific research conducted on neurodegenerative disorders at Harvard Medical School/Brigham and Women’s Hospital, Duke University, and the University of Texas-Southwestern Medical Center, where she earned her Ph.D. degree.

Buy report Login to access report
Back to all Market Assessment reports
Buy report
Login to access report

launch Related Market Assessment Reports